The past decade has been marked by the acceleration of our
understanding of the molecular biology of cancer. Simultaneously,
there have been increasing exigencies to diagnose, treat and follow
cancer patients more economically. Biomarkers represent the
marriage of science and economics. Biomarkers offer the potential
to increase the precision of diagnosis, prognosis, and surveillance
of urological malignancies. This issue presents the cutting-edge
advances of biomarker technology to urologic oncology.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!